Treatment Strategy for Rifampin-Susceptible Tuberculosis. Reply

N Engl J Med. 2023 Jun 15;388(24):2298. doi: 10.1056/NEJMc2304776.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Rifampin* / pharmacology
  • Rifampin* / therapeutic use
  • Tuberculosis* / drug therapy

Substances

  • Rifampin